View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. News
March 27, 2018

Canadian study finds daily ibuprofen can prevent Alzheimer’s

A new study carried out by Canadian researchers suggests that a daily dose of ibuprofen can prevent Alzheimer’s disease.

A new study carried out by Canadian researchers suggests that a daily dose of ibuprofen can prevent Alzheimer’s disease.

Led by neuroscientist and Aurin Biotech president and CEO Dr Patrick McGeer, the team concluded that if started early enough, the non-prescription drug can ‘ward off’ the neurodegenerative disease.

The findings are based on a saliva test developed by McGeer and his team in 2016 to measure the peptide amyloid-beta protein 42 (Abeta 42) levels to diagnose and predict Alzheimer’s.

People who are at risk of developing the disease have higher rates of Abeta 42 production, as the protein is relatively insoluble and gets accumulated in brain. These deposits lead to neuroinflammation and neuron destruction in Alzheimer’s patients.

“Knowing that the prevalence of clinical Alzheimer’s Disease commences at age 65, we recommend that people get tested ten years before, at age 55, when the onset of Alzheimer’s would typically begin.”

This gives patients an opportunity to begin taking early preventive measures such as consuming non-prescription non-steroidal drugs including ibuprofen.

McGeer said: “Knowing that the prevalence of clinical Alzheimer’s Disease commences at age 65, we recommend that people get tested ten years before, at age 55, when the onset of Alzheimer’s would typically begin.

“If they exhibit elevated Abeta 42 levels then, that is the time to begin taking daily ibuprofen to ward off the disease.”

Statistics show that 47 million people suffer from Alzheimer’s, with more than $818bn in healthcare costs incurred each year.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU